Literature DB >> 16787890

Traditional toxicity documentation of Chinese Materia Medica--an overview.

Albert Y Leung1.   

Abstract

Documentation of Chinese materia medica (CMM) dates back to around 1,100 BC when only dozens of drugs were first described. By the end of the 16th century, the number of drugs documented had reached close to 1,900. And by the end of the last century, published records of CMM have reached 12,800 drugs. The recorded traditional information includes toxicities, incompatibilities, cautions, precautions and contraindications. Thus, contrary to a general misconception, toxicity data on Chinese herbs exist and are not meager. If consulted properly before embarking on a study of CMM, it will save researchers much time and efforts and the frustration of not obtaining consistent or expected results. The history of documentation is reviewed with examples of major classic and contemporary works highlighting and emphasizing the manner in which CMM toxicities have traditionally been documented through clinical experience as opposed to most modern toxicity data that are based on animal experimentation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787890     DOI: 10.1080/01926230600773958

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  10 in total

Review 1.  Traditional Chinese Medicine "Pill", an Ancient Dosage Form with Surprising Modern Pharmaceutical Characteristics.

Authors:  Jieyu Zuo; Chulhun Park; Janice Yu Chen Kung; Nádia Araci Bou-Chacra; Michael Doschak; Raimar Löbenberg
Journal:  Pharm Res       Date:  2021-02-18       Impact factor: 4.200

2.  Fractionation analysis and health risk assessment of heavy metals in six traditional Chinese medicines.

Authors:  Guanjun Nan; Xianxin Meng; Ning Song; Zhengzheng Liu; Yu Liu; Guangde Yang
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-14       Impact factor: 4.223

3.  Herbal medicine research and global health: an ethical analysis.

Authors:  Jon C Tilburt; Ted J Kaptchuk
Journal:  Bull World Health Organ       Date:  2008-08       Impact factor: 9.408

Review 4.  The quality of reports of randomized clinical trials on traditional Chinese medicine treatments: a systematic review of articles indexed in the China National Knowledge Infrastructure database from 2005 to 2012.

Authors:  Jinnong Li; Zhenhua Liu; Ruiqi Chen; Dan Hu; Wenjuan Li; Xiajing Li; Xuzheng Chen; Baokang Huang; Lianming Liao
Journal:  BMC Complement Altern Med       Date:  2014-09-26       Impact factor: 3.659

5.  Drug-induced liver injury associated with Complementary and Alternative Medicine: a review of adverse event reports in an Asian community from 2009 to 2014.

Authors:  Desmond Chun Hwee Teo; Patricia Suet Leng Ng; Siew Har Tan; Adena Theen Lim; Dorothy Su Lin Toh; Sui Yung Chan; Han Hui Cheong
Journal:  BMC Complement Altern Med       Date:  2016-07-07       Impact factor: 3.659

6.  Pro-inflammatory effect of a traditional Chinese medicine formula with potent anti-cancer activity in vitro impedes tumor inhibitory potential in vivo.

Authors:  Lei Xia; Maksym Plachynta; Tangjingjun Liu; Xiao Xiao; Jialei Song; Xiaogang Li; Mu Zhang; Yao Yao; Heng Luo; Xiaojiang Hao; Yaacov Ben-David
Journal:  Mol Clin Oncol       Date:  2016-10-24

7.  Unlocking the potential of natural products in drug discovery.

Authors:  Gerard D Wright
Journal:  Microb Biotechnol       Date:  2018-12-19       Impact factor: 5.813

8.  UPLC-MS/MS Method for the Simultaneous Quantification of Eight Compounds in Rat Plasma and Its Application to a Pharmacokinetic Study after Oral Administration of Veratrum (Veratrum nigrum L.) Extract.

Authors:  Yuqi Fan; Lulu Zhao; Xuhua Huang; Jiayuan Shen; Wei Wang; Xiaohua Jia; Mengyuan Gao; Huizi Ouyang; Yanxu Chang; Jun He
Journal:  Biomed Res Int       Date:  2020-10-19       Impact factor: 3.411

Review 9.  Cytochrome P450 enzyme mediated herbal drug interactions (Part 2).

Authors:  Sompon Wanwimolruk; Kamonrat Phopin; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2014-08-20       Impact factor: 4.068

Review 10.  Diabetic Osteoporosis: A Review of Its Traditional Chinese Medicinal Use and Clinical and Preclinical Research.

Authors:  Rufeng Ma; Ruyuan Zhu; Lili Wang; Yubo Guo; Chenyue Liu; Haixia Liu; Fengwei Liu; Hongjun Li; Yu Li; Min Fu; Dongwei Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-06       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.